CLINICAL_TRIALS
trial_result
· 2024-02-09
Clinical Trial Update: Predictors of Intravenous Ketamine Response in TRD [Phase 3]
Summary
A Phase 3 trial update investigating predictors of intravenous ketamine response in treatment-resistant depression and major depressive disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abraham Nunes | Conditions: Treatment Resistant Depression, Major Depressive Disorder | Phase 3 | Status: UNKNOWN